Anteris Technologies Glob... (AVR)
The price, the headline numbers and the latest news, in one place.
Anteris Technologies Global Corp. (AVR) Stock Price, Analysis & Data
| Bid | 5.95 |
| Market Cap | 871.21M |
| Revenue (ttm) | 2.24M |
| Net Income (ttm) | -103.56M |
| n/a | |
| -1.96 | |
| n/a | |
| -9.27 | |
| P/B (ttm) | 3.47 |
| P/S (ttm) | 388.59 |
| Earnings Date | Nov 12, 2026 |
| Ask | 10.57 |
| Volume | 558,838 |
| Avg. Volume (20D) | 1,162,725 |
| Open | 8.86 |
| Previous Close | 8.89 |
| Day's Range | 8.75 - 9.04 |
| 52-Week Range | 3.30 - 11.05 |
| Analyst | Strong Buy |
| Price Target | 15 (67.60%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About AVR
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification prepa...
Financial Performance
In 2025, Anteris Global's revenue was 1.91M, a decrease of -29.23% compared to the previous year's 2.7M. Earnings were -94.14M, an increase of 23.4%.
Financial StatementsAnalyst Forecast
According to 3 analyst ratings, the average rating for AVR stock is "Strong Buy". The 12-month stock price forecast is 15, which is upside of 67.6% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $494K misses estimates by $0, with -11.15% YoY decline.
- EPS of -0.3 misses estimates by -0.09, with 50.82% YoY growth.
Analysts project revenue of ... Upgrade
